Bromocriptine-induced implantation during lactation in the rat

Area of Science:

• Reproductive biology
• Endocrinology
• Animal models

Background:

• Lactational anestrus is a common phenomenon in mammals, preventing further pregnancy during nursing.
• Hormonal regulation plays a crucial role in the initiation and maintenance of pregnancy, including implantation.

Purpose of the Study:

• To investigate the effect of bromocriptine, a dopamine agonist, on inducing implantation in lactating rats.
• To compare the efficacy of bromocriptine treatment versus litter removal in facilitating implantation.

Main Methods:

• Lactating rats were mated at post-partum oestrus.
• A single dose of bromocriptine (2 mg/kg body weight) was administered 7 days post-mating.
• Litter removal was performed in some groups at the time of bromocriptine treatment.
• Implantation status was assessed on Day 11 post-mating.

Main Results:

• Bromocriptine treatment induced implantation in 33.3% (8/24) of lactating rats.
• In rats where the litter was removed concurrently with bromocriptine treatment, 55.6% (5/9) exhibited implantation.
• Litter removal alone resulted in a higher implantation rate of 90% (9/10).

Conclusions:

• Bromocriptine can overcome lactational anestrus to induce implantation in rats.
• Litter removal is a more effective method than bromocriptine treatment for promoting implantation in this model.
• These findings highlight the complex interplay of hormonal and environmental factors in regulating reproductive success during lactation.